Veritas Capital announced it has entered into a definitive agreement, through an affiliate, to acquire a majority stake in Global Healthcare Exchange, a supply chain software platform that connects healthcare providers and suppliers. Existing shareholders Temasek and Warburg Pincus will remain invested alongside Veritas and support the company’s growth strategy. Financial terms were not disclosed.
GHX provides cloud-based supply chain solutions that digitize and automate processes spanning procurement, connectivity, and related workflows between providers and suppliers. The company said its platform combines a unified data core across product, vendor, transactional, clinical, and operational domains with AI-driven automation and decision support tools aimed at improving resiliency, reducing waste, and lowering costs across healthcare supply chains.
The companies said the investment will accelerate GHX’s product innovation and AI roadmap, with a focus on simplifying workflows, generating actionable insights, and automating decision-making for customers. GHX said it serves a broad network that includes Gartner’s top 25 U.S. healthcare systems and the top 30 medical-surgical suppliers globally, and that its solutions have driven more than $27 billion in savings over the past three years.
The transaction is expected to close in the first quarter of 2026, subject to customary closing conditions, including regulatory approvals.
Support: Evercore advised GHX financially. Cleary Gottlieb Steen & Hamilton advised GHX and Temasek, Gibson Dunn advised Veritas, and Kirkland & Ellis advised Warburg Pincus.
KEY QUOTES:
“This investment enables us to move faster and think bigger about building a more resilient, AI-enabled supply chain. Veritas recognizes our unique role in facilitating better, more affordable patient care, and they bring deep experience scaling healthcare technology companies that matter. This partnership will help us further invest in product innovation, pursue both organic and inorganic growth, and amplify our AI-powered supply chain strategy. It is a strong affirmation of our strategy, our people and the opportunity ahead.”
Tina Vatanka Murphy, President and CEO, GHX
“We have long admired the vital role GHX plays in lowering the cost of care and enabling resilient supply chains. We see many parallels between GHX and prior scaled healthcare technology investments by Veritas at the intersection of mission-critical data and real-time decision making. We look forward to leveraging these experiences to support Tina and her team on their journey to reimagine the healthcare supply chain, with an overarching common goal of driving better patient outcomes.”
Ramzi Musallam, CEO and Managing Partner, Veritas Capital
“Since 2017, we have supported GHX through key phases of transformation, strengthening its position as a leading integrated, data-driven platform. Veritas’ acquisition of a majority stake extends the strong partnership we have had with Warburg Pincus and supports the next stage of GHX’s growth. This is aligned with our conviction that digitization underpins stronger and more resilient healthcare supply chains.”
Ravi Lambah, Head of Strategic Initiatives, Temasek
“Our conviction in GHX and the value of our partnership is as strong as ever, and Veritas’ investment is a further confirmation of the enduring value that GHX provides across the healthcare industry. We are pleased to continue our work with the Company to help expand its reach, serving customers around the world.”
Adam Krainson, Managing Director, Warburg Pincus
